MedPath

Ketanserin

Generic Name
Ketanserin
Drug Type
Small Molecule
Chemical Formula
C22H22FN3O3
CAS Number
74050-98-9
Unique Ingredient Identifier
97F9DE4CT4

Overview

Ketanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.

Background

Ketanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Effect of Ketanserin After LSD Administration
Phase 1
Completed
Posted: 2020/09/22
Sponsor:
University Hospital,...
ID:NCT04558294
Ketanserin Effects on Peripheral Temperature and Lactate
Phase 4
Posted: 2018/08/24
Sponsor:
Onze Lieve Vrouwe Ga...
ID:NCT03646318
The Neurobiological Effect of 5-HT2AR Modulation
Phase 1
Recruiting
Posted: 2017/09/21
Sponsor:
Gitte Moos Knudsen
ID:NCT03289949
Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers
Phase 1
Completed
Posted: 2015/12/17
Sponsor:University of Guadal...
ID:NCT02632877
The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers
Not Applicable
Completed
Posted: 2015/05/21
Sponsor:
Psychiatric Universi...
ID:NCT02451072

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy